What is the prognosis of each Revised International Prognostic Scoring System (IPSS-R) myelodysplastic syndrome (MDS) risk group?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print
Answer

With the IPSS, patients were stratified tinofour risk groups: low, intermediate 1 and 2, and high. The IPSS-R score is used to stratify patients into five risk groups, as shown in Table 1, below:

Table 1. Revised International Prognostic Scoring System risk groups and prognosis [18] (Open Table in a new window)

Risk Group

Time to Development of AML (y)

Median Survival (y)

Very low

NR

8.8

Low

10.8

5.3

Intermediate

3.2

3.0

High

1.4

1.6

Very High

0.7

0.8

AML – Acute myelogenous leukemia


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!